The solution should be clear and colourless
Lancet Neurol
Signal Transduction and Targeted Therapy , 9(1), 234
At 24 weeks, least-squares mean changes from baseline in HbA1c with retatrutide were 0.43% for the 0.5 mg group, 1.39% for the 4 mg escalation group, 1.30% for the 4 mg group, 1.99% for the 8 mg slow escalation group, 1.88% for the 8 mg fast escalation group, and 2.02% for the 12 mg escalation group, versus 0.01% for the placebo group and 1.41% for the 1.5 mg dulaglutide group
Reta FAQs Is Reta approved for human use
Tesamorelin signals the pituitary gland to release growth hormone, which raises IGF-1 levels and preferentially mobilizes visceral fat, an effect that is typically assessed over months rather than weeks